Skip to main content

Table 2 Patients clinical, medical and laboratory information

From: Predictors of poor health-related quality of life among hemodialysis patients with anemia in Jordan

Variable N (%)
Cause of ESRD
 HTN 38 (22.8)
 DM 43 (25.8)
 HTN and DM 12 (7.2)
 Glomerulonephritis 5 (2.9)
 Others 2 (1.2)
  Drugs 1 (0.6)
  Medical error 66 (39.3)
  Unknown 69 (41.7)
Number of prescribed medications
 < 5 19 (11.6)
 5–10 90 (54.9)
 > 10 55 (33.5)
Vascular access for HD
 Catheter 39 (23.2)
 Fistula 117 (69.6)
 Graft 12 (7.2)
Dialysis sessions per week
 2 Times weekly 16 (9.5)
 3 Times weekly 152 (90.5)
Length of dialysis session in hours
 3 h or less 32 (19.1)
 3.5 h 57 (33.9)
 4 h or more 79 (47.0)
Years under dialysis
 < 2 years 51 (30.4)
 2–5 years 52 (30.9)
 > 5 years 65 (38.7)
Patients on iron products 149 (88.7)
Patients on erythropoietin 159 (94.6)
Psychiatric symptomsa
 HADS-A 5.2 (± 4.5)
 HADS-D 6.4 (± 4.9)
 HADS-T 11.6 (± 8.9)
Patients had practiced exercise last week 37 (22.16)
Duration of exercise per week in minutesa 148.11 (± 126.3)
Number of emergency visits last yeara 2.94 (± 4.18)
Number of hospital admissions last yeara 1.66 (± 2.19)
Serum creatininea (normal range 0.7–1.3 mg/dL) 9.22 (± 2.69)
Serum urea# (normal range: 2.5–7.1 mmol/L) 21.36 (± 6.76)
Calcium levela (normal range 2.2–2.6 mmol/L) 2.18 (± 0.23)
Potassium levela (normal range 3.5–5.0 mmol/L) 5.29 (± 0.83)
Parathyroid hormonea (normal range 10–65 ng/L) 633.7 (± 626.8)
Irona (normal range 11–29 μmol/L) 9.43 (± 11.46)
Hemoglobina (normal range male 14–17, female 12–16 g/dL) 10.27 (± 1.59)
Total iron binding capacitya (normal range 250–460 μg/dL) 233.97 (± 45.47)
Serum ferritina (normal range 15–200 ng/mL) 458.58 (± 640.36)
  1. HTN, hypertension; DM, diabetes mellitus; HADS-A, hospital anxiety and depression scale-anxiety; HADS-D, hospital anxiety and depression scale-depression; HADS-T, hospital anxiety and depression scale-total
  2. aData are presented as mean (± SD)